Lack of association or linkage disequilibrium between schizophrenia and polymorphisms in the 5-HT1Dα and 5-HT1Dβ autoreceptor genes: Family-based association study

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 128 B, Issue 1, 2004, Pages 1-5

  Ambrósio, Alda M ^a   Kennedy, James L ^b   Macciardi, Fabio ^b   Coelho, Isabel ^c   Soares, Maria J ^c   Oliveira, Catarina R ^a   Pato, Carlos N ^d,e  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^e Veterans Administration   (United States)

Author keywords

Candidate genes; Haplotypes; Introduction; Linkage disequilibrium; Serotoninergic system

Indexed keywords

AUTORECEPTOR; SEROTONIN 1D ALPHA RECEPTOR; SEROTONIN 1D BETA RECEPTOR; SEROTONIN 1D RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; DNA POLYMORPHISM; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PORTUGAL; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 3042847445     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30023     Document Type: Article

References (44)

1. Azevedo MH, Dourado A, Valente J, Macedo A, Coelho I, Pato M, Pato C. 1993. The Portuguese-Language version of diagnostic interview for genetic studies. Psychiatr Genet 3:189.
2. Barnes NM, Sharp T. 1999. A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152.
3. Baron M. 2001. Genetics of schizophrenia and the new millennium: Progress and pitfalls. Am J Hum Genet 68:299-312.
4. Blackwood DHR, Fordyce A, Walker MT, Clair DM, Porteous DJ, Muir WJ. 2001. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: Clinical and P300 findings in a family. Am J Hum Genet 69:428-433.
5. Bleich A, Brown S, Kahn R, Van Pragg H. 1988. The role of serotonin in schizophrenia. Schizophr Bull 14:297-315.
6. Brzustowicz LM, Hodgkinson KA, Chow EWC, Honer WG, Bassett AS. 2000. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 288:678-682.
7. Clayton D. 1999. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 65:1170-1177.
8. Coelho I, Macedo A, Valente J, Dourado A, Ambrósio A, King N, Azevedo MH, Kennedy JL, Pato CN, Pato MT. 1997. Association study of serotonin receptors and schizophrenia in a portuguese population. Psiquiatria Clínica 18:41-47.
9. Collins FS, Guyer MS, Chakravarti A. 1997. Variations on the theme: Cataloging human DNA sequence variation. Science 278:1580-1581.
10. Demchyshyn L, Sunahara R, Miller K, Teitler M, Hoffman BJ, Kennedy JL, Seeman P, Van Tol HHM, Niznik HB. 1992. A human serotonin 1D receptor variant (5HT1Dβ) encoded by an intronless gene on chromosome 6. Proc Natl Acad Sci USA 89:5522-5526.
11. 3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist. Naunyn-Schmiedeberg's Arch Pharmacol 356:328-334.
12. Gaster LM, Blaney FE, Davies S, Duckworth DM, Ham P, Jenkins S, Jennings AJ, Joiner GF, King FD, Mulholland KR, Wyman PA, Hagan JJ, Hatcher J, Jones BJ, Middlemiss DN, Price GW, Riley G, Roberts C, Routledge C, Selkirk J, Slade PD. 1998. The selective 5-HT1B receptor inverse agonist 1′-methyl-5- [[2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl] carbonyl]-2,3,6,7-tetrahydro-spiro[furo[2,3-f]indole-3,4′-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. J Med Chem 41(8):1218-1235.
13. Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS, Read T, Murphy P, Blaveri E, McQuillin A, Petursson H, Curtis D. 2001. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosome 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet 68:661-673.
14. Hamblin MW, Metcalf MA. 1991. Primary structure and functional characterization of a human 5T1D-type serotonin receptor. Mol Pharmacol 40:143-148.
15. Hovatta L, Varilo T, Suvisaari J, Terwilliger JD, Ollikainen V, Arajarvi R, Juvonen H, Kokko-Sahin M-L, Vaisanen L, Mannila H, Lonnqvist J, Peltonen L. 1999. A genomewide screen for schizophrenia genes in a isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am J Hum Genet 65:1114-1124.
16. Hwu H-G, Lin M-W, Lee P-C, Lee F-C, Ou-Yang W-C, Liu C-M. 2000. Evaluation of linkage of markers on chromosome 6p with schizophrenia in Taiwanese families. Am J Med Genet 96:74-78.
17. 1Breceptor. J Biol Chem 267:5735-5738.
18. Kapur S, Remington G. 1996. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 153(4):466-476.
19. Kunovac JL, Stahl SM. 1995. Biochemical pharmacology of serotonin receptor subtypes: Hypotheses for clinical applications of selective serotonin ligands. Int Rev Psychiatry 7:55-67.
20. Lander ES. 1996. The new genomics: Global views of biology. Science 274:1594-1595.
21. Lappalainen J, Dean M, Charbonneau L, Virkkunen M, Linnoila M, Goldman D. 1995. Mapping of the serotonin 5-HT1Dα autoreceptor gene on chromosome 6 and direct analysis for sequence variants. Am J Med Genet 60:157-161.
22. Libert F, Passage E, Parmentier M, Simons MJ, Vassart G, Mattei MG. 1991. Chromosomal mapping of A1 and A2 adenosine receptors, VIP receptor, and a new subtype of serotonin receptor. Genomics 11:225-227.
23. Martinez M, Goldi L, Cao Q, Zhang J, Sanders AR, Nancarrow DJ, Taylor JM, Levinson DF, Kirby A, Crowe RR, Andreasen NC, Black DW, Silverman JM, Lennon DP, Nertney DA, Brown D, Mowry BJ, Gershon ES, Gejman PV. 1999. Follow-up study on a susceptibility locus for schizophrenia on chromosome 6q. Am J Med Genet 83:337-343.
24. McGuffin P, Farmer AE, Harvey JL. 1991. Apolydiagnostic application of the operational criteria in studies of psychotic illness. Arch Gen Psychiatry 48:764-770.
25. Meltzer HY. 1987. Biological studies in schizophrenia. Schizophr Bull 13:77-111.
26. Miller SA, Dykes DD, Plesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
27. Nothen MM, Erdmann J, Shimron-Abarbanell D, Propping P. 1994. Identification of genetic variation in the human serotonin 1Dβ receptor gene. Biochem Biophys Res Commun 205(2):1194-1200.
28. Nurnberger JL, Blehar MC, Kaufmann CA, York-Cooler C, Simpson S, Har-Kavy-Friedman J, Severe J, Malaspina D, Reich T. 1994. Collaborators from NIMH Genetics Initiative. Diagnostic Interview for Genetics Studies. Rationale, unique features, and training. Arch Gen Psychiatry 51:849-859.
29. Ott J. 1989. Statistical properties of the haplotype relative risk. Genet Epidemiol 6:127-130.
30. Ozaki N, Lappalainen J, Dean M, Virkkunen M, Linnoila M, Goldman D. 1995. Mapping of the serotonin 5-Ht1Dα autoreceptor gene (HTR1D) on chromosome 1 using a silent polymorphism in the coding region. Am J Med Genet 60:162-164.
31. Pato CN, Macedo A, Ambrosio A, Vincent JB, Bauer A, Schindler K, Xu J, Coelho I, Dourado A, Valente J, Azevedo MH, Kennedy JL, Pato MT. 2000. Detection of expansion regions in Portuguese bipolar families. Am J Med Genetic 96:854-857.
32. Powers RE. 1999. The neuropathology of schizophrenia. J Neuropathol Exp Neurology 58:679-690.
33. Prasad S, Semwal P, Deshpande S, Bhatia T, Nimgaonkar VL, Telma BK. 2002. Molecular genetics of schizophrenia: Past, present and future. J Biosci 27:35-52.
34. Riley BP, McGuffin P. 2000. Linkage and association studies of schizophrenia. Am J Med Genet 97:23-44.
35. Risch N, Merikangas K. 1996. The future of the genetic studies of complex human disease. Science 273:1516-1517.
36. Schaid DJ, Sommer SS. 1994. Comparison of statistics for candidate-gene association studies using cases and parents. Am J Hum Genet 55:402-409.
37. Schindler K, Torre C, Bauer A, Medeiros H, Carvalho C, Fernandes LF, Pato MT, Pato CN. 1999. Identification of a highly homogenous population for genetic study of psychiatric disorders. CNC Spectrums 4(5): 22-24.
38. Schindler KM, Pato MT, Dourado A, Macedo A, Azevedo MH, Kennedy JL, Pato CN. 2002. Association and linkage disequilibrium between a functional polymorphism of the dopamine-2 receptor gene and schizophrenia in a genetically homogeneous Portuguese population. Mol Psychiatry 7(9):1002-1005.
39. Sidenberg DG, Basset AS, Demchyshyn L, Niznik HB, Macciardi F, Kamble AB, Honer WG, Kennedy JL. 1993. New polymorphism for human serotonin 1D receptor variant (5-HT1Dβ) not linked to schizophrenia in five canadian pedigrees. Hum Hered 43:315-318.
40. Spielman RS, Ewens WJ. 1998. A sibship test for linkage in the presence of association: The sib transmission/disequilibrium test. Am J Hum Genet 62:450-458.
41. Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage desequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516.
42. Terwilliger JD, Ott J. 1992. A haplotype based haplotype relative risk approach to detecting allelic associations. Hum Hered 42:337-346.
43. Weinshank RL, Zgombick JM, Maccihi MJ, Branchek TA, Harting PR. 1992. HT1Dα and 5-HT1Dα. Proc Natl Acad Sci USA 89:3630-3634.
44. Xu J, Pato MT, Torre CD, Medeiros H, Carvalho C, Basile VS, Bauer A, Dourado A, Valente J, Soares MJ, Macedo A, Coelho I, Ferreira CP, Azevedo MH, Macciardi F, Kennedy JL, Pato CN. 2001. Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azores families. Am J Med Genet 105:669-674.